<em>Medtronic, Inc. v. Teleflex Life Scis. Ltd.</em>

The Federal Circuit affirmed the Patent Trials and Appeals Board’s decision on the validity of Teleflex’s patent but refused to address whether an in vivo performance of an in vivo method is required to show actual reduction to practice.